Stefano Baiocchi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Stefano Baiocchi has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Angelo Balestrazzi
Department of Ophthalmology and Neurosurgery, University of Siena, Siena, Italy
1 shared publication Claudio Traversi
Ophthalmology Speciality School Siena University
1 shared publication- Cosimo Mazzotta
Department of Medicine and Surgery, University of Enna “Kore”, Piazza dell’Università, 94100 Enna, Italy
1 shared publication - Frederik Raiskup
Department of Ophthalmology, Carl Gustav Carus University Hospital, Dresden, Germany
1 shared publication - Gaia Cartocci
Emergency Radiology Unit, Diagnostic Medicine and Radiology, Umberto I University Hospital, Sapienza University of Rome, Italy
1 shared publication - Gian Marco Tosi
Ophthalmology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy
1 shared publication
Latest Publications
- 9 November 2017
- Published by Springer Nature
- p. 1-31
Principles of Accelerated Corneal Collagen Cross-Linking
- 9 November 2017
- Published by Springer Nature
- p. 1-31
Principles of Accelerated Corneal Collagen Cross-Linking
- Open Access
- 27 February 2015
- Published by Springer Nature in Eye
- Vol. 29 (5) , 637-642
Mini-incision cataract surgery and toric lens implantation for the reduction of high myopic astigmatism in patients with pellucid marginal degeneration
To evaluate the clinical outcomes, safety, and efficacy of cataract surgery with the implantation of a toric intraocular lens (IOL) in eyes with stable pellucid marginal degeneration (PMD). Eleven eyes (eight patients) diagnosed as stable PMD and cataract underwent mini-incision 2.2 mm cataract surgery followed by the implantation of hydrophobic toric aspheric IOL (AcrySof IQ Toric IOL, Alcon, Fort Worth, TX, USA). Perioperative variables of interest included uncorrected (UDVA) and corrected (CDVA) distance visual acuities, manifest refraction, and corneal topography. Paired samples t-tests were used to analyze preoperative and postoperative visual acuity, astigmatism, and spherical equivalent (SE) parameters. Follow-up was 6 months. The mean CDVA was 0.62±0.26 logMAR preoperatively and 0.07±0.07 logMAR postoperatively. The mean preoperative sphere and cylinder was -3.14±3.58D and -4.84±2.02D, respectively. The mean postoperative manifest refractive sphere and cylinder was -0.30±0.51D and -0.81±1.51D, respectively. There was a significant reduction in refractive astigmatism after toric IOL implantation (P<0.002). The toric IOL axis rotation was <5° in all cases at the final follow-up. Implantation of hydrophobic toric IOL was a safe and effective surgical procedure to correct mild to moderate stable PMD.
- 27 February 2015
- Published by Springer Nature in Eye
- Vol. 29 (5) , 637-642
Open AccessMini-incision cataract surgery and toric lens implantation for the reduction of high myopic astigmatism in patients with pellucid marginal degeneration
To evaluate the clinical outcomes, safety, and efficacy of cataract surgery with the implantation of a toric intraocular lens (IOL) in eyes with stable pellucid marginal degeneration (PMD). Eleven eyes (eight patients) diagnosed as stable PMD and cataract underwent mini-incision 2.2 mm cataract surgery followed by the implantation of hydrophobic toric aspheric IOL (AcrySof IQ Toric IOL, Alcon, Fort Worth, TX, USA). Perioperative variables of interest included uncorrected (UDVA) and corrected (CDVA) distance visual acuities, manifest refraction, and corneal topography. Paired samples t-tests were used to analyze preoperative and postoperative visual acuity, astigmatism, and spherical equivalent (SE) parameters. Follow-up was 6 months. The mean CDVA was 0.62±0.26 logMAR preoperatively and 0.07±0.07 logMAR postoperatively. The mean preoperative sphere and cylinder was -3.14±3.58D and -4.84±2.02D, respectively. The mean postoperative manifest refractive sphere and cylinder was -0.30±0.51D and -0.81±1.51D, respectively. There was a significant reduction in refractive astigmatism after toric IOL implantation (P<0.002). The toric IOL axis rotation was <5° in all cases at the final follow-up. Implantation of hydrophobic toric IOL was a safe and effective surgical procedure to correct mild to moderate stable PMD.